RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model

Title
RANKL inhibition is an effective adjuvant for docetaxel in a prostate cancer bone metastases model
Authors
Keywords
-
Journal
PROSTATE
Volume 68, Issue 8, Pages 820-829
Publisher
Wiley
Online
2008-03-07
DOI
10.1002/pros.20744

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now